We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

News   Mar 01, 2019 | Original Press Release from the Advanced Science Research Center at the Graduate Center of the City University of New York

 
Metabolite Drug Tackles Multiple Sclerosis by Altering T Cells' Epigenetic Landscape

Fumaric Acid Ester Metabolites act as a regulator of the micro RNA MIR-21, which is necessary to create the brain-homing T cells that are active in multiple sclerosis. Credit: Carter Eitreim

 
 
 

RELATED ARTICLES

Mild Cognitive Impairment and Signaling Explored With MRS Scan

News

Whereas magnetic resonance imaging primarily measures the brain’s water, magnetic resonance spectroscopy has been long used to identify metabolites based on “signature” peaks of the substances generated in response to certain vibrations.

READ MORE

Zika Study May "Supercharge" Vaccine Research

News

Scientists looking at the genetics of Zika virus have found a way to fast-track research which could lead to new vaccines.

READ MORE

Mass Spec Study Backs Remarkable Parkinson's Smell Test

News

A skin swab test for Parkinson's has become a real possibility, after mass spectrometry was used to detect altered levels of specific compounds on the skin of people with the condition. The research is a result of the incredible ability of one woman to detect a unique odor on the skin of people with Parkinson's disease. These findings open the door to a non-invasive screening test.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE